Analysts think SER stock price could increase by 143%
Aug 09, 2025, 11:25 AM
-1.56%
What does SER do
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
3 analysts think SER stock price will increase by 143.30%. The current median analyst target is $13.26 compared to a current stock price of $5.45. The lowest analysts target is $11.11 and the highest analyst target is $15.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
